Arena Pharmaceuticals Announces First Subject Dosed in Phase 2 Trial Evaluating Etrasimod in Alopecia Areata
On September 1st, 2020, Arena Pharmaceuticals announced that the first subject has been dosed in Phase 2 of their trial evaluating a
CSPA Survey: Access to Dermatology Care
The Canadian Skin Patient Alliance (CSPA) is conducting a survey on the impact of COVID-19 on access to dermatology care. Please take
Research Articles on Healthcare Inequalities in Canada
CANAAF stand with the Black community in the fight against anti-Black racism! #BlackLivesMatter! Minority populations, especially Black and Indigenous communities, are likely